Status:
ACTIVE_NOT_RECRUITING
Cognitive Muscular Therapy for Patients With Long-COVID and Breathing Pattern Disorder
Lead Sponsor:
University of Salford
Conditions:
Long COVID
Respiratory Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of the study is to test a treatment known as "Cognitive Muscular Therapy (CMT)" for reducing breathlessness and improving autonomic function in patients with long-COVID.
Detailed Description
A key symptom of long-COVID is dysfunctional breathing, characterised by an alteration in the muscular and mechanical control of breathing, such as altered movement/coordination of diaphragm and ribs....
Eligibility Criteria
Inclusion
- Above 18 years old
- Experience moderate/severe breathlessness, quantified using the Modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) scale.
- Speak and understand English sufficiently to read the information sheet and sign the consent form
- Ability to stand without any assistive device for at least 20 minutes (to ensure sufficient capacity to complete the intervention)
Exclusion
- Dementia or other major cognitive impairment
- BMI \>32 (as increased subcutaneous fat prevents use of breathing measurement system)
- Current smoker or smoked regularly within last 6 months
- Any cardiorespiratory disease that requires medical intervention (except asthma management)
- Currently receiving physiotherapy-based treatment for LC or breathing pattern disorder
- Significant respiratory co-morbidity (e.g. COPD, uncontrolled Asthma)
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06503913
Start Date
August 1 2024
End Date
April 1 2026
Last Update
December 2 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Salford
Manchester, Greater Manchester, United Kingdom, M6 6PU